Skip to the story

International / No single location · Science & Health

New obesity medications show fewer side effects than GLP-1

Rank
Ran
30h
Updated
2d ago
Closed
Outlets
4
Regions
3
Countries
4
Languages
4

+0

Stuff New Zealand · English 6 Oct, 15:00 UTC

The only English report

Read it also in Eesti (1) · Español (1) · Português (1) · +2 languages

Read at Stuff

How it spread

Outlets covering the story by hours since its first article: one at the start, 4 after 31 hours.

1 2 3 4
0h 6h 12h 18h 24h 30h

Outlets, by hours since the first article

  1. First outlet: Estadão, 5 Oct, 08:30 UTC.
  2. Second country: Argentina, with Infobae.
  3. Second region: Europe, with Postimees.
  4. Last article: 4 outlets.

Where it travelled

31 of 31 hours

Earlier Later

The 4 countries whose press covered it, the later a country joined, the more it stands out. Open the live map

The regions

50%25%25%

  • Americas 2 outlets · 2 countries · 50%
  • Asia-Pacific 1 outlet · 1 country · 25%
  • Europe 1 outlet · 1 country · 25%

First movers

  1. Estadão 5 Oct, 08:30 UTC
  2. Infobae +22h 1m
  3. Postimees +25h 30m
  4. Stuff +30h 30m

The figures

Coverage
4 outlets in 4 countries, across 3 regions. The article links are kept for good for every story that reaches the map. Of the 4 outlets, 4 private. A count of countries is not a count of independent press systems.
Countries by region
Americas 2: Argentina, Brazil. Asia-Pacific 1: New Zealand. Europe 1: Estonia. The region a country’s press publishes from, as the feed list files it; the outlets that publish from no single country count as one country under International.
Languages
English, Spanish, Estonian, Portuguese.
Timeline
Earliest article Estadão, 5 Oct 2026, 08:30 UTC. First seen 5 Oct 2026, 08:40 UTC. Last seen 6 Oct 2026, 15:00 UTC. The earliest article is the earliest claimed publication time among the outlets Loudest reads, a claim rather than an observation and not a record of who broke the story (the data files call it the lead article); first seen is when Loudest first fetched an article of it, from which the running time counts.
Classification
Region International. Topic Science & health. Hard news Judged not hard news. Left off the map. Whether the story is hard news under the rule in the methodology, judged from its headlines by a model; a story judged outside the rule is left off the map and kept here. The region and country are where the story is about, not where it was covered.
Score
None now: last seen more than 48 hours ago, so off the ranking. One vote per general-press country and a smaller term for outlets, each counted from the moment it joined the story and fading on its own clock, so a late article does not renew the rest. A day in the archive keeps the score it was ranked by that day.
Chain
Continued by Study tests strategies to prevent weight regain from GLP-1 drugs. A story continues another when it resembled it as it began, past that story’s own 48-hour box.

This record as JSON, CC BY 4.0.

How this was measured

This page describes measured coverage: which of the outlets Loudest reads carried the story, from how many countries and in how many languages, and when. It says nothing about whether the story is true, important or well reported.

Started 5 Oct, 08:40 UTC · Updated 6 Oct, 15:00 UTC · Final figures at midnight UTC

Covered by 4 outlets

Pin outlets you trust with ☆ and they come first in every story.

Americas 2 outlets

  • Infobae Argentina 6 Oct, 06:30 UTC
    La nueva clase de medicamentos para adelgazar puede tener menos efectos secundarios que los GLP-1
  • Estadão Brazil 5 Oct, 08:30 UTC
    Canetas para obesidade ajudam a proteger os rins e o coração? Veja o que se sabe

Asia-Pacific 1 outlet

  • Stuff New Zealand 6 Oct, 15:00 UTC
    The hidden side effect of weight-loss drugs that you won’t know about

Europe 1 outlet

  • Postimees Estonia 6 Oct, 10:00 UTC
    Uus kaalulangetusravim päästab patsiendid GLP-1 ravimite piinavaimast kõrvalmõjust
Read at Stuff

Loudest reads the world's press every ten minutes and sizes each story by how widely it is covered.

Live map Archive Data Sources Methodology About Privacy & terms